已核实 DOI PubMed 相关产品: 0

Honokiol improves cognitive impairment in APP/PS1 mice through activating mitophagy and mitochondrial unfolded protein response

Journal 2021 · IF 5.194 · 发表于 2021 年 11 月 6 日
作者: Mingyue Hou,Wenfang Bao,Yuanyuan Gao,Jiayue Chen,Guijun Song
阅读全文 在 PubMed 查看

摘要

Activated mitophagy and mitochondrial unfolded protein response (UPR mt ) has been reported to protect against mitochondrial dysfunction, which is closely related to the onset of Alzheimer's disease (AD). Honokiol (HKL, C 18 H 18 O 2 ) is a kind of natural extraction from bark of Magnolia offi cinalis with anti-AD effect, and our study aims to explore the effect of HKL on mitophagy and UPR mt in AD. Briefly, male APP/PS1 mice and Aβ oligmer (AβO)-treated primary hippocampal neurons were respectively used to mimic AD in vivo and in vitro. It was determined that HKL significantly ameliorated cognitive impairment and synaptic damages in APP/PS1 mice. Besides, the activated mitophagy and UPR mt together with inhibited oxidative stress and improved mitochondrial dynamic disorder were further validated in hippocampus of HKL-treated APP/PS1 mice. Meanwhile, HKL-treated mice displayed much higher hippocampal expression and activity of mitochondrial sirtuin 3 (SIRT3). Therefore, SIRT3 knockdown was further achieved in primary hippocampal neurons by effective shRNA , and we determined that HKL improved synaptic damage, mitochondrial dysfunction, mitophagy and UPR mt in AβO-treated primary hippocampal neurons in a SIRT3-dependent manner. In summary, our study validates the protective effect of HKL on AD, and highlights that HKL exerts anti-AD effect by activating mitophagy and UPR mt .